血液透析患者抗高血压药物使用情况及用药护理措施

Use of antihypertensive drugs and nursing measures in hemodialysis patien ts

目的:分析血液透析患者抗高血压药物使用情况,并制定针对性的用药护理方案,旨在为后续用药及护理工作提供科学指导。方法:将血液透析患者作为本次分析样本,样本选取时间为2020年8月—2023年8月,样本数据共计100例,收集抗高血压药物的使用处方,实施用药护理干预,分析血液透析的药物清除效果。结果:抗高血压药物使用占比中,钙通道阻滞剂、血管紧张素Ⅱ受体拮抗剂、血管紧张素转化酶抑制剂占比较高,分别为30.00%、26.00%、16.00%;在血液透析中,贝那普利、福辛普利以及培哚普利等抗高血压药物不易被清除,但多数药物会被透析清除。结论:抗高血压药物对血液透析患者血压的控制具有积极意义,但多数药物会被透析清除,临床上需对相关用药护理干预给予高度重视,进而实现最佳的血压控制效果。

Objective:To analyze the use of antihypertensive drugs in hemodialysis patients,and to develop targeted medication nursing plans,in order to provide scientific guidance for subsequent medication and nursing work.Methods:Hemodialysis patients were selected as samples for this analysis.The samples were selected from August 2020 to August 2023,and a total of 100 samples were collected.The prescription of antihypertensive drugs was collected,medication nursing intervention was implemented,and the drug clearance effect of hemodialysis was analyzed.Results:Calcium channel blockers,angiotensin II receptor antagonists and angiotensin converting enzyme inhibitors accounted for the highest proportion of antihypertensive drugs,which were 30.00%,26.00%and 16.00%,respectively.Antihypertensive drugs such as Benazepril,fosinopril and perindopril are not easily cleared during hemodialysis,but most drugs are cleared by dialysis.Conclusion:Antihypertensive drugs have positive significance in blood pressure control of hemodialysis patients,but most of the drugs will be cleared by dialysis.Clinical attention should be paid to related medication nursing intervention to achieve the best blood pressure control effect.